Diabetes

By Jonah Comstock November 16, 2018
Four years after announcing an ambitious — and often ridiculed — project to create a glucose-sensing contact lens along with Novartis subsidiary Alcon, Alphabet's Verily is throwing in the towel, the company announced in a blog post today. It will continue to work on two other medical contact lens projects, aimed at presbyopia and cataract surgery recovery. "Our clinical work on the glucose-...
By Jonah Comstock November 1, 2018
Just a short while after securing a CE Mark for its second generation device, Abbott has been granted FDA clearance for FreeStyle LibreLink, a companion mobile app for its 10 to 14-day CGM. The launch adds a long-awaited feature for US users that’s been available for some time in Europe: users will be able to scan their sensors with an app on their smartphone — and see their latest reading —...
By Dave Muoio October 3, 2018
Pediatric and adult Type 1 diabetes patients receiving a hybrid closed-loop artificial pancreas therapy demonstrated improved glucose control and lower risk of hypoglycemia compared to those managing their own glucose levels with an insulin pump and continuous glucose monitor, according to a study published today in the Lancet. The investigation, which was supported by JDRF and presented at the...

The Freestyle Libre 1.

By Jonah Comstock October 1, 2018
Abbott has received CE Mark clearance for the second generation of its Freestyle Libre device, which will allow the company to make the device available to users in Europe. It will be rolled out gradually in Europe starting in the next few weeks, and it will be offered as the same price as the first generation device. Freestyle Libre 1, which has been available in Europe since 2014, is a fully...
By Dave Muoio September 6, 2018
Diabetes is a costly chronic condition, and according to the International Diabetes Federation affects at least 425 million people worldwide. As such, it’s little surprise that an increasing number of digital health companies have spotted an opportunity to help patients manage and control their disease. In fact, that opportunity led the total revenue digital diabetes market to triple in 2017 to $...
By Jonah Comstock September 5, 2018
Correction: A previous version of this article failed to specify that the deal concerns Freestyle Libre Pro, rather than the consumer version, Freestyle Libre. Livongo Health, the digital chronic disease management company founded by former Allscripts CEO Glen Tullman, announced today that it will be the first United States enterprise diabetes management company to bring Abbott’s Freestyle Libre...
By Dave Muoio July 11, 2018
In 2016, UnitedHealthcare and Medtronic cut a deal that established the latter’s devices as the preferred insulin pumps for United members with diabetes. Now, the companies have announced year one data suggesting that members who took advantage of the companies’ arrangement experienced fewer preventable hospital admissions when compared to members relying on multiple daily injections of insulin...
By Dave Muoio July 9, 2018
Researchers from the University of Waterloo have described a proof-of-concept system that uses Google’s Soli — an experimental, radar-based gesture tracker co-developed with Infineon — to track concentrations of glucoses within a solution. With further investigation and adjustment, this prototype technology could potentially be implemented for diabetes patients as a novel noninvasive approach to...
By Jonah Comstock July 2, 2018
Healthy Interactions, a population health company that offers both digital and in-person programs for chronic disease management and education, announced last week that it has added two new programs, for cardiovascular disease and depression, to its portfolio.  The company's initial focus was on diabetes, and it launched its original program, diabetes self-management education and support, in...
By Jonah Comstock June 25, 2018
Working with digital diabetes prevention program (DPP) provider Omada Health — and combining that intervention with lab and biometric screenings — lab company Quest Diagnostics reduced risk for diabetes in one-third of a 107-employee cohort. "Many employers are eager to implement employee wellness programs that drive better health and cost outcomes, but are unsure of how best to achieve these...